Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-027945
Filing Date
2018-05-14
Accepted
2018-05-14 12:18:15
Documents
52
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv493283_10q.htm 10-Q 270875
2 EXHIBIT 31.1 tv493283_ex31-1.htm EX-31.1 9894
3 EXHIBIT 31.2 tv493283_ex31-2.htm EX-31.2 9874
4 EXHIBIT 32.1 tv493283_ex32-1.htm EX-32.1 4902
5 EXHIBIT 99.1 tv493283_ex99-1.htm EX-99.1 64776
6 GRAPHIC tv493283_img1.jpg GRAPHIC 28491
7 GRAPHIC logo.jpg GRAPHIC 1602
  Complete submission text file 0001144204-18-027945.txt   2462909

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT fencf-20180331.xml EX-101.INS 435320
9 XBRL TAXONOMY EXTENSION SCHEMA fencf-20180331.xsd EX-101.SCH 34874
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20180331_cal.xml EX-101.CAL 16385
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20180331_def.xml EX-101.DEF 184167
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20180331_lab.xml EX-101.LAB 218133
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20180331_pre.xml EX-101.PRE 206864
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 18829459
SIC: 2836 Biological Products, (No Diagnostic Substances)